BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu Y, Wang L, Pan D, Yan J, Wang X, Yang R, Li M, Liu Y, Yang M. Synthesis of a novel 89Zr-labeled HER2 affibody and its application study in tumor PET imaging. EJNMMI Res 2020;10:58. [PMID: 32495181 DOI: 10.1186/s13550-020-00649-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Rinne SS, Orlova A, Tolmachev V. PET and SPECT Imaging of the EGFR Family (RTK Class I) in Oncology. Int J Mol Sci 2021;22:3663. [PMID: 33915894 DOI: 10.3390/ijms22073663] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Wen L, Xia L, Guo X, Huang HF, Wang F, Yang XT, Yang Z, Zhu H. Multimodal Imaging Technology Effectively Monitors HER2 Expression in Tumors Using Trastuzumab-Coupled Organic Nanoparticles in Patient-Derived Xenograft Mice Models. Front Oncol 2021;11:778728. [PMID: 34869025 DOI: 10.3389/fonc.2021.778728] [Reference Citation Analysis]
3 Manafi-farid R, Ataeinia B, Ranjbar S, Jamshidi Araghi Z, Moradi MM, Pirich C, Beheshti M. ImmunoPET: Antibody-Based PET Imaging in Solid Tumors. Front Med 2022;9:916693. [DOI: 10.3389/fmed.2022.916693] [Reference Citation Analysis]
4 Yadav D, Kumar R, Phulia A, Basu S, Alavi A. Molecular Imaging Assessment of Hormonally Sensitive Breast Cancer: An Appraisal of 2-[18F]-Fluoro-2-Deoxy-Glucose and Newer Non-2-[18F]-Fluoro-2-Deoxy-Glucose PET Tracers. PET Clin 2022;17:399-413. [PMID: 35717099 DOI: 10.1016/j.cpet.2022.04.001] [Reference Citation Analysis]
5 Liu S, Tong Z, Jiang C, Gao C, Xu J, Mu X, Liu B, Du B, Liu Z, Zhang P. Phage Display Affibodies Combined with AuNPs@Ru(bpy)32+ for Ultra-Sensitive Electrochemiluminescence Detection of Abrin. Chemosensors 2022;10:184. [DOI: 10.3390/chemosensors10050184] [Reference Citation Analysis]
6 Hu X, Li D, Fu Y, Zheng J, Feng Z, Cai J, Wang P. Advances in the Application of Radionuclide-Labeled HER2 Affibody for the Diagnosis and Treatment of Ovarian Cancer. Front Oncol 2022;12:917439. [DOI: 10.3389/fonc.2022.917439] [Reference Citation Analysis]